Sign In

Christian Macher

Country President & Oncology General Manager at Novartis

Christian Macher is currently the VP & General Manager of Gilead Sciences Germany, a position he has held since August 2022.2 Prior to this, he served as the Country President & Oncology General Manager at Novartis in Canada from May 2019 to August 2022.2

Macher is an experienced pharmaceutical industry executive with over 25 years in the field.2 He has held leadership positions at several major companies, including:

  • AstraZeneca: Global Product & Portfolio Strategy Oncology - Head of Faslodex (2016-2018)
  • AstraZeneca: Country President in Taiwan (2012-2016)
  • Procter & Gamble: Various marketing director roles (2005-2009)

He holds a PhD in Chemistry and is passionate about transformative medicines, health tech, and innovative ways of working.2 At Novartis, Macher was known for promoting a culture of flexibility and empowerment, emphasizing collaboration and co-creation in the workplace.1 He played an active role in policy and government relations, serving on the boards of Innovative Medicines Canada and Montreal In-Vivo.12

Macher is committed to shaping the future of global health, fostering innovation, and creating strategic partnerships to address major health challenges.2

Highlights

Nov 10 · wework.com
A forward-thinking pharmaceutical company goes hybrid - WeWork
May 8 · newswire.ca
Novartis Canada announces Christian Macher as country President

Related Questions

What are Christian Macher's key achievements at Novartis?
How has Christian Macher influenced the pharmaceutical industry?
What is Christian Macher's background before joining Novartis?
How does Christian Macher's leadership style impact his team?
What are the main challenges Christian Macher has faced in his role at Novartis?
Christian Macher
Add to my network

Location

Canada